Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.
Zhu AX, Kudo M, Assenat E, Cattan S, Kang YK, Lim HY, Poon RT, Blanc JF, Vogel A, Chen CL, Dorval E, Peck-Radosavljevic M, Santoro A, Daniele B, Furuse J, Jappe A, Perraud K, Anak O, Sellami DB, Chen LT.
Zhu AX, et al. Among authors: furuse j.
JAMA. 2014 Jul 2;312(1):57-67. doi: 10.1001/jama.2014.7189.
JAMA. 2014.
PMID: 25058218
Clinical Trial.